Cerevast Therapeutics Receives $1,780,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6e4b6500-7f2d-4fdd-aace-38b26a66c5fd
Date
11/26/2013
Company Name
Cerevast Therapeutics
Mailing Address
12277 134th Court NE Redmond, WA 98052
Company Description
Cerevast Therapeutics, Inc. is a medical technology company with primary emphasis in the field of SonoLysis for the treatment acute ischemic stroke and other vascular disorders.
Website
http://www.cerevast.com
Transaction Type
Debt
Transaction Amount
$1,780,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
M&A Terms
Venture Investor
Undisclosed